Regulation of androgen metabolism by the nuclear receptor CAR
核受体 CAR 对雄激素代谢的调节
基本信息
- 批准号:7415245
- 负责人:
- 金额:$ 8.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-05-01 至 2009-04-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAndrogen MetabolismAndrogensAnimalsBiological AvailabilityCYP3A4 geneCancer EtiologyCessation of lifeChemicalsCytochrome P450DevelopmentDrug Metabolic DetoxicationEnzymesExposure toGSTP1 geneGene TargetingGenesGlutathione S-TransferaseGoalsHomeostasisKnockout MiceLiverMalignant neoplasm of prostateMediatingMetabolismMolecularNuclear ReceptorsPathway interactionsPhenobarbitalPrevention therapyProstateRegulationRegulatory PathwayRoleSerumSiteTestingTestosteroneTranscriptional RegulationUnited StatesXenobioticscancer preventioncarcinogenesisconstitutive androstane receptorcytochrome P450 3Ahormone metabolismhuman CYP2B6 proteinimprintmenmetabolic abnormality assessmentneonatal exposurenovel strategiesoxidationprenatalresearch studysmall moleculesteroid hormonesteroid metabolism
项目摘要
DESCRIPTION (provided by applicant):
Prostate cancer is the second leading cause of cancer death among men in the United States. Abnormal levels of androgen due to deregulation of hormone metabolism have been implicated in the initiation and progression of prostate cancer. However, the mechanism of regulating androgen, particularly testosterone metabolism and inactivation is still unknown. Constitutive Androstane Receptor (CAR) is a master regulator in the metabolism and detoxification of both xenobiotics and endobiotics including steroid hormones. Several lines of evidence suggest that CAR may regulate the androgen metabolism: 1. Two P450 enzymes involved in testosterone oxidation, CYP2B and CYP3A, are primary target genes regulated by CAR. 2. Prenatal and neonatal exposure to Phenobarbital, a prototypical CAR activator, results in P450 enzyme imprinting and permanently changes the levels of testosterone. 3. CAR is expressed in the liver and prostate, the two major sites for androgen metabolism. Our long-term goal is to delineate the regulatory pathway of androgen metabolism and its impact on prostate carcinogenesis. We hypothesize that CAR controls an important pathway of androgen metabolism in liver and prostate and deregulation of this pathway changes the bioavailability of androgen, thus affecting prostate carcinogenesis. We propose three specific aims to test our hypothesis: Specific Aim1. Determine the role of CAR in testosterone metabolism in liver and prostate. We will compare the wild type and our CAR knockout mice after treating the animals with CAR activators to determine the role of CAR in androgen metabolism. Specific Aim 2. Investigate the role of CAR in early developmental imprinting of P450 enzymes in testosterone metabolism and its effect on prostate carcinogenesis. We will first determine the role of CAR in mediating the P450 enzyme imprinting and then investigate the impact of this early developmental imprinting on prostate carcinogenesis. Specific Aim 3. Study the transcriptional regulation of GSTP1 gene by CAR in the prostate. Results from experiments outlined here will illustrate an important pathway in androgen metabolism and provide better understanding of the molecular mechanism of androgen homeostasis. Manipulation of CAR activity by small molecules may be a novel approach for prostate cancer prevention and therapy.
描述(由申请人提供):
前列腺癌是美国男性癌症死亡的第二大原因。由于激素代谢失调导致的雄激素水平异常与前列腺癌的发生和发展有关。然而,调节雄激素,特别是睾酮代谢和失活的机制仍然是未知的。组成型雄烷受体(CAR)是外源性物质和内源性物质(包括类固醇激素)代谢和解毒的主要调节剂。有几条证据表明CAR可能调节雄激素代谢:1.参与睾酮氧化的两种P450酶CYP2B和CYP3A是CAR调控的主要靶基因。2.产前和新生儿暴露于苯巴比妥(一种典型的CAR激活剂)会导致P450酶印迹并永久改变睾酮水平。3. CAR在肝脏和前列腺中表达,这是雄激素代谢的两个主要部位。我们的长期目标是阐明雄激素代谢的调节途径及其对前列腺癌发生的影响。我们假设CAR控制肝脏和前列腺中雄激素代谢的重要途径,并且该途径的失调改变了雄激素的生物利用度,从而影响前列腺癌的发生。我们提出了三个具体目标来检验我们的假设:具体目标1。确定CAR在肝脏和前列腺睾酮代谢中的作用。我们将在用CAR激活剂治疗动物后比较野生型和我们的CAR敲除小鼠,以确定CAR在雄激素代谢中的作用。具体目标2。研究CAR在睾酮代谢中P450酶的早期发育印记中的作用及其对前列腺癌发生的影响。我们将首先确定CAR在介导P450酶印迹中的作用,然后研究这种早期发育印迹对前列腺癌发生的影响。具体目标3。研究CAR对前列腺GST P1基因的转录调控。从这里概述的实验结果将说明雄激素代谢的一个重要途径,并提供更好地了解雄激素稳态的分子机制。通过小分子操纵CAR活性可能是前列腺癌预防和治疗的新方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WENDONG HUANG其他文献
WENDONG HUANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WENDONG HUANG', 18)}}的其他基金
Intestinal Regulation of Gut Microbiota and Metabolism
肠道微生物群和新陈代谢的调节
- 批准号:
10411864 - 财政年份:2021
- 资助金额:
$ 8.45万 - 项目类别:
MiRNAs in hepatocellular carcinoma development and treatment
miRNA 在肝细胞癌发生和治疗中的作用
- 批准号:
9413314 - 财政年份:2011
- 资助金额:
$ 8.45万 - 项目类别:
INVESTIGATION OF THE ROLES OF NUCLEAR RECEPTOR FXR IN HEPATOCELLULAR
核受体 FXR 在肝细胞中的作用研究
- 批准号:
8042520 - 财政年份:2011
- 资助金额:
$ 8.45万 - 项目类别:
INVESTIGATION OF THE ROLES OF NUCLEAR RECEPTOR FXR IN HEPATOCELLULAR
核受体 FXR 在肝细胞中的作用研究
- 批准号:
8403839 - 财政年份:2011
- 资助金额:
$ 8.45万 - 项目类别:
MiRNAs in hepatocellular carcinoma development and treatment
miRNA 在肝细胞癌发生和治疗中的作用
- 批准号:
9239522 - 财政年份:2011
- 资助金额:
$ 8.45万 - 项目类别:
INVESTIGATION OF THE ROLES OF NUCLEAR RECEPTOR FXR IN HEPATOCELLULAR
核受体 FXR 在肝细胞中的作用研究
- 批准号:
8215639 - 财政年份:2011
- 资助金额:
$ 8.45万 - 项目类别:
相似海外基金
Regulation of Androgen Metabolism in Frog Development
青蛙发育中雄激素代谢的调节
- 批准号:
418576-2012 - 财政年份:2019
- 资助金额:
$ 8.45万 - 项目类别:
Discovery Grants Program - Individual
Regulation of Androgen Metabolism in Frog Development
青蛙发育中雄激素代谢的调节
- 批准号:
418576-2012 - 财政年份:2018
- 资助金额:
$ 8.45万 - 项目类别:
Discovery Grants Program - Individual
Regulation of Androgen Metabolism in Frog Development
青蛙发育中雄激素代谢的调节
- 批准号:
418576-2012 - 财政年份:2017
- 资助金额:
$ 8.45万 - 项目类别:
Discovery Grants Program - Individual
Regulation of Androgen Metabolism in Frog Development
青蛙发育中雄激素代谢的调节
- 批准号:
418576-2012 - 财政年份:2016
- 资助金额:
$ 8.45万 - 项目类别:
Discovery Grants Program - Individual
Regulation of Androgen Metabolism in Frog Development
青蛙发育中雄激素代谢的调节
- 批准号:
418576-2012 - 财政年份:2015
- 资助金额:
$ 8.45万 - 项目类别:
Discovery Grants Program - Individual
Regulation of Androgen Metabolism in Frog Development
青蛙发育中雄激素代谢的调节
- 批准号:
418576-2012 - 财政年份:2014
- 资助金额:
$ 8.45万 - 项目类别:
Discovery Grants Program - Individual
Regulation of Androgen Metabolism in Frog Development
青蛙发育中雄激素代谢的调节
- 批准号:
418576-2012 - 财政年份:2013
- 资助金额:
$ 8.45万 - 项目类别:
Discovery Grants Program - Individual
Regulation of Androgen Metabolism in Frog Development
青蛙发育中雄激素代谢的调节
- 批准号:
418576-2012 - 财政年份:2012
- 资助金额:
$ 8.45万 - 项目类别:
Discovery Grants Program - Individual
Selenium, Isoflavones, Androgen Metabolism and Prostate Cancer Risk Reduction
硒、异黄酮、雄激素代谢和降低前列腺癌风险
- 批准号:
7847355 - 财政年份:2009
- 资助金额:
$ 8.45万 - 项目类别:
ROLES OF INFLAMMATION AND ANDROGEN METABOLISM IN PROSTATE CANCER DISPARITY
炎症和雄激素代谢在前列腺癌差异中的作用
- 批准号:
7305658 - 财政年份:2007
- 资助金额:
$ 8.45万 - 项目类别: